Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab-Reference-Cited by-同舟云学术

Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab

Published:2023-09 Issue:9 Volume:143 Page:1822-1825.e3
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Dekkers Coco^ORCID,der Wal M. Marlot van^ORCID,El Amrani Mohsin^ORCID,Luin Matthijs van^ORCID,Bakker Daphne S.^ORCID,Bruin-Weller Marjolein de^ORCID,van Wijk Femke^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference9 articles.

1. A generic sample preparation method for the multiplex analysis of seven therapeutic monoclonal antibodies in human plasma or serum with liquid chromatography-tandem mass spectrometry;Amrani;J Chromatogr A,2021

2. Early and long-term effects of dupilumab treatment on circulating T-cell functions in patients with moderate-to-severe atopic dermatitis;Bakker;J Invest Dermatol,2021

3. Comprehensive analysis of human IL -4 receptor subunits shows compartmentalization in steady state and dupilumab treatment;Heeb;Allergy,2023

4. Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis;Spekhorst;Allergy,2022

5. Biomarkers for atopic dermatitis: a systematic review and meta-analysis;Thijs;Curr Opin Allergy Clin Immunol,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital;Journal of the European Academy of Dermatology and Venereology;2023-09-25

2. IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval;Clinical & Experimental Allergy;2023-09-12